# Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED)

> **NCT00390260** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 420 (—)

## Conditions studied

- Pain, Postoperative Arthroscopy

## Interventions

- **DRUG:** MK0966 / Duration of Treatment: 1 Days
- **DRUG:** Comparator: acetaminophen (+) hydrocodone bitartrate / Duration of Treatment: 1 Days
- **DRUG:** Comparator: placebo (unspecified) / Duration of Treatment: 1 Days

## Key facts

- **NCT ID:** NCT00390260
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2003-02
- **Final completion:** 2003-02
- **Target enrollment:** 420 (—)
- **Last updated:** 2017-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00390260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00390260, "Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00390260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*